2016-05-30-世界卫生组织-Diabetes_Sri_Lanka_2016_country_profile_1页_340kb

报告摘要

Sri Lanka Diabetes Report Summary

Population and Income: Sri Lanka's total population is 20,715,000, classified as a lower middle-income country.
Mortality Rates: Diabetes-related deaths are high, accounting for a significant proportion of total deaths among ages 30–69 and 70+. Specifically, there are over 4,000 diabetes-attributable deaths in each age group for males and females combined, with high blood glucose as a key factor. Mortality estimates have high uncertainty due to reliance on international data rather than national NCD statistics.
Other Health Causes of Death: Cardiovascular diseases and communicable, maternal, perinatal, and nutritional conditions contribute substantially to mortality. Injuries are also a significant cause.
Prevalence and Risk Factors: The age-standardized diabetes prevalence is 7.9%, with risk factors including overweight (26.1%, national average), obesity (6.8%), and physical inactivity (23.7%) among males and females.
National Response: Sri Lanka has an operational policy for diabetes, along with partial implementation of guidelines and referral criteria. However, no operational policy exists for reducing overweight and obesity, and policies for reducing physical inactivity are in place. Diabetes registry and comprehensive national risk factor surveys are absent, though some basic medicines and technologies (e.g., insulin and blood glucose measurement) are available in primary care, while others (e.g., HbA1c test) are not.
Resource Availability: Essential diabetes medicines and technologies are present in some parts of the public health sector, but availability varies, with key services like renal replacement therapy being generally available. Medicines and technologies not listed are often scarce.
Key Uncertainties and Trends: The data shows high diabetes mortality and rising prevalence, but this is overshadowed by other health burdens, and strategies for full implementation are limited.